GLS2 and breast cancer: GATA3’s involvement in amino acid metabolism regulation is supported by studies in breast cancer, where Glutaminase 2 (GLS2), transcriptionally regulated by the estrogen receptor co-factor GATA3, is more common in hormone receptor-positive tumors [70,71].